Project Number 132 Agency/Funding Organization Alzheimer's Society UK|The Bupa Foundation Funding Year 2010 View Full Project Details for Oligodendrocyte Progenitor Cells: A New Target for Alzheimer's Disease Treatment. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 4. ApoE and Lipid Neurobiology h. Myelin Researcher and Organization Principal Investigator Small, Surr Principal Investigator First Name Surr Principal Investigator Last Name Small Awardee Organization University of Tasmania & UCL Contact PI Country Australia Project Detail FY Overall Cost $268,779 Funding Organization Agency/Funding Organization Alzheimer's Society UK|The Bupa Foundation Funding Organization Country United Kingdom
